AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (1779)	12/24/2003 11:35:22 AM
From: arnie h	Read Replies (1) of 2173

Stock price seems to be holding up pretty well considering the delay in any Symlin approval and allegations about disclosing actionable material privately to GS. I listened to the CC and didn't find anything that would be concerning with regard to improper disclosure but that would be a problem if it did occur in the GS call. I thought the price would drop to about the $18 level where Lily got in. That it hasn't seems positive to me. Any thoughts?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next